Oncology focused biotech to utilise 4basebio’s opDNA® technology to support Phase II clinical trial of immunotherapy candidate Multi-year, seven-figure revenue stream reflecting increased commercial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results